Last Updated on October 10, 2024 by The Health Master
Hyderabad: Pharma major Abbott India Limited recalled an entire batch of Thyronorm tablets. The batch was sent to Madhya Pradesh and Telangana.
The batch has been wrongly labelled with a lesser dose, compared to what it actually contains. The high dosage can cause serious reactions if taken.
“Attention of the general public is drawn to the fact that Abbott India Limited has issued a voluntary recall of one batch of Thyronorm tablets (Thyroxine Sodium) of Batch No. AEJ0713, manufacturing date of March 2023.
This is due to the labelling error in a small percentage of bottles from this batch which have been mislabled with the dose strength of 25 mcg, whereas the bottle contain 88 mcg tablets,” the firm said in a public notice.
AdvtOverdose of this drug could cause nervousness, insomnia, mild tremors in hand, tachycardia, mild elevation in body temperature, blood pressure elevation and diarrhoea.
In extreme cases, it could lead to coma, psychosis and even myocardial infraction in elderly patients, said experts.
The pharma company has urged citizens in these two states, who have recently purchased Thyronorm (batch no AEJ0713, manufacturing March 2023 and expiry date of February 2025) to return the bottles to the chemist or notify the company on email ID: webmasterindia@abbott.com.
Drug recall: Sun Pharma, Hetero recall these drugs
Drug recall: 50,000 contaminated eye drops recalled
Drug recall: 55,000 bottles of Colchicine tablets due to this reason
Drug recall: Brimonidine Tartrate Ophthalmic Solution recalled due to this reason
Drug recall: 4,000 bottles of Tacrolimus Capsules recalled due to this reason
Drug recall: Artificial Tears Lubricant Eye Drops recalled due to this reason
Govt likely to announce National Medical Device Policy
UK MHRA gives marketing authorisation for Cisplatin
Drug alert: 48 out of 1497 samples declared as NSQ in March 2023
USFDA issues directive to Sun Pharma for corrective action: Mohali
Drug recall: Sun Pharma, Hetero recall these drugs
Medical Device alert: USFDA identifies recall of this Medical Device as most serious
FDCA issued 2,267 new manufacturing licences in 2020-23: Gujarat
Wet Granulation vs Dry Granulation: Understanding the Key Differences
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
